Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK
Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

DSIJ Intelligence Article rating: 4.3

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway
Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway

Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway

The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years.

DSIJ Intelligence-1 Article rating: 3.7

The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years.

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today
Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent.

DSIJ Intelligence-1 Article rating: 3.1

The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent.

Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News
Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News

Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.

DSIJ Intelligence Article rating: 5.0

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.

Market Crash: Sensex & Nifty Down Over 1.8 Per Cent, Midcap & Smallcap Indices Plunge Upto 2.5 Per Cent
Market Crash: Sensex & Nifty Down Over 1.8 Per Cent, Midcap & Smallcap Indices Plunge Upto 2.5 Per Cent

Market Crash: Sensex & Nifty Down Over 1.8 Per Cent, Midcap & Smallcap Indices Plunge Upto 2.5 Per Cent

The Nifty 50 closed down by 1.86 per cent to 22,124.70, and the Sensex fell by 1.90 per cent to 73,198.10.

DSIJ Intelligence Article rating: 1.0

Market breadth was extremely negative, with 489 advances and 2,416 declines, indicating a severe negative sentiment prevailing among investors.

Aatmanirbhar Bharat Boost: Tata Power’s TP Solar Secures Rs 632 Crore Contract from Government of India
Aatmanirbhar Bharat Boost: Tata Power’s TP Solar Secures Rs 632 Crore Contract from Government of India

Aatmanirbhar Bharat Boost: Tata Power’s TP Solar Secures Rs 632 Crore Contract from Government of India

By securing this contract, TP Solar cements its position as a leading solar module manufacturer in India and significantly contributes to the government’s Aatmanirbhar Bharat vision

DSIJ Intelligence Article rating: 4.0

By securing this contract, TP Solar cements its position as a leading solar module manufacturer in India and significantly contributes to the government’s Aatmanirbhar Bharat vision

Are Neobanks Safe? The Hidden Risks No One Talks About
Are Neobanks Safe? The Hidden Risks No One Talks About

Are Neobanks Safe? The Hidden Risks No One Talks About

Neobanks offer convenience, but hidden risks could put your money at stake. Are they truly safe?

DSIJ Intelligence Article rating: 5.0

Neobanks offer convenience, but hidden risks could put your money at stake. Are they truly safe?

RSS
First169170171172174176177178Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR